Cite

HARVARD Citation

    Gillis, N. et al. (2014). Clinical Implementation of Germ Line Cancer Pharmacogenetic Variants During the Next‐Generation Sequencing Era. Clinical pharmacology & therapeutics. 95 (3), pp. 269-280. [Online]. 
  
Back to record